Top compounds associated with response to NRROS


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 4e-07
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 5e-07
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 7e-07
mRNA Axitinib CTRPv2 pan-cancer AAC 0.22 8e-07
mRNA GDC-0879 CTRPv2 pan-cancer AAC 0.23 1e-06
mRNA regorafenib CTRPv2 pan-cancer AAC 0.24 1e-06
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 2e-06
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 2e-06
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 3e-06
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.22 3e-06
Download CSV